TrialMultiple sclerosis (Houndmills, Basingstoke, England)2018

The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies.

Mark S Freedman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.